Back to DE D. E. Shaw & Co., Inc.
ORKA
4 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Oruka Therapeutics, Inc.
No. D. E. Shaw exited its ORKA (Oruka Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 76,415 shares worth $2.3M. D. E. Shaw first reported ORKA in Q2 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$758,300
Total Shares Change
-67,645
Quarter-by-Quarter History